Frontline Doctor Highlights His Preferred COVID-19 Treatments

5Mind. The Meme Platform
The Epoch Times Header

While the Omicron variant of the  the CCP (Chinese Communist Party) virus seems to be causing less severe disease than the Delta variant, it’s still landing some people in hospitals, highlighting the need for effective treatment before cases progress to that stage, a frontline doctor says.

Dr. Syed Haider has treated more than 4,000 COVID-19-positive patients so far during the pandemic. Just five ended up going to a hospital, and none have died.

The doctor said his preferred treatments include many off-label medications along with vitamins and supplements.

“Vitamin D is really important, ivermectin is important, fluvoxamine, hydroxychloroquine also works, it’s just a lot of people have been convinced that it doesn’t at this point, and are scared off of trying it,” Haider told NTD’s “Capitol Report.” “But I prefer ivermectin, fluvoxamine, Vitamin D, Vitamin C, quercetin, zinc.”

Ivermectin is an anti-parasitic that has had mixed results against COVID-19 in clinical trials and isn’t advised by the Food and Drug Administration to treat the disease. Fluvoxamine is an antidepressant that’s gaining popularity for use against COVID-19. Hydroxychloroquine is an anti-malarial that has shown some success in treating the disease. Quercetin is a plant pigment that’s not widely known yet as a treatment for COVID-19.

Haider has also recommended flax seed oil.

“One really easy thing that anyone can do is just follow the directions on a bottle of hydrogen peroxide, you can get this at the store, can dilute it down to 1 percent swish swish it through your nose, or swish it through your mouth and drip it into your nose or use a neti pot to rinse out your nose. And it’s not uncomfortable, it shouldn’t be burning, if it’s burning, you would want to dilute it a little bit more, and that kills the virus on contact,” he said.

Haider’s list differs from the National Institutes of Health’s recently updated treatment recommendations for non hospitalized COVID-19 patients.

The agency recommends using Pfizer’s COVID-19 pill, known as paxlovid; Merck’s pill, called molnupiravir; GlaxoSmithKline’s monoclonal antibody treatment, sotrovimab; or Gilead Sciences’s remdesivir, administered through IV over multiple days.

The recommendations stem from studies that demonstrate the therapeutics’ effectiveness, the agency said.

Haider, however, doesn’t agree with the remdesivir recommendation, noting it’s never received an endorsement from the World Health Organization and that it has the side effect of causing kidney failure.

The virus that causes COVID-19, he said, is “very, very easily treatable” if early treatment is done with off-label drugs, Haider stressed.

He advises people get prepared ahead of time.

“I think people need to take this seriously and get medications on hand before they get sick,” Dr. Syed Haider told “Capitol Report.”

While Omicron often manifests as a bad cold, even some people who are considered at low-risk of developing severe disease will end up with severe cases, the doctor said. Additionally, emerging data indicate that the protection provided by both vaccination and natural immunity isn’t as good against Omicron, emphasizing the need to be ready.

By Zachary Stieber

Read Original Article on TheEpochTimes.com

Contact Your Elected Officials
The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Congress fumbles college sports

College sports landscape is a dumpster fire and every sports reporter, broadcaster and fan believes Congress needs to stay out of it.

The Hating Game

The Democrat Party game show should be titled "The Hating Game", played by pitting one class, race, or identity against another for political power.

The Invasion Of The Ballot Snatchers

As election results loom, California faces ballot controversies in a real-life political drama that raises concerns about election integrity.

The politics of perception

Shapiro relies on big-money fundraising, while Garrity’s campaign emphasizes local support and fiscal discipline.

The Coming Tsunami of AI Entertainment

If AI replaces creativity, critical thinking, imagination, discipline, and effort, it could be the greatest enabler of human decline.

Investigation Reveals 1 in 4 Popular Grocery Items Contains Excessive Additives

Analysis of 40 popular food products found 25% contained additives exceeding established safety consumption thresholds.

Hegseth Visits Guantanamo Bay Amid Rising Tensions With Cuba

Sec. of War Pete Hegseth on June 10 is visiting U.S. forces in Cuba and at the headquarters of the U.S. CENTCOM in Florida amid tensions in mission areas.

Trump Signs $70 Billion Bill to Fund ICE, Border Patrol for 3 Years

President Donald Trump on June 10 signed a $72 billion bill on June 10 to fund Immigration and Customs Enforcement (ICE) and Border Patrol.

Studies Cited by RFK Jr., Others Involved in Vaccine Changes Face Blowback

Journals retracted or removed two papers, and are investigating at least two others, based in part on complaints from self-identified vaccine advocates.

Trump Says US ‘Not Looking to Renew’ Trade Deal With Canada, Mexico Ahead of July Review

President Trump is considering not renewing the North American free trade deal, citing U.S. being better off without goods produced by Canada and Mexico.

DOJ Says It Will Comply With Court’s Block on ‘Anti-Weaponization Fund’

The Justice Department has hit pause on a proposed anti-weaponization fund after an unfavorable court ruling.

Trump Suggests Vance’s Anti-Fraud Efforts Could Save Social Security

The president made the comment at a Cabinet meeting...

Trump’s Triumphal Arch Approved by Federal Commission

A commission has approved President Donald Trump’s triumphal arch just outside of Washington, a key step toward making the project a reality.
spot_img

Related Articles

Popular Categories

MAGA Business Central